Update Venetoclax in CLL
Zanubrutinib
Acalabrutinib
(Update) Acalabrutinib in CLL and MCL
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
UpToDate
Patient Power
NCCN Guidelines for Patients